Literature DB >> 19429699

Evaluation of insulin sensitivity with a new lipid-based index in non-diabetic postmenopausal overweight and obese women before and after a weight loss intervention.

Barbara Antuna-Puente1, Emmanuel Disse, May Faraj, Marie-Eve Lavoie, Martine Laville, Rémi Rabasa-Lhoret, Jean-Philippe Bastard.   

Abstract

OBJECTIVE: To evaluate the validity of a new lipid-based index (Disse index) in assessing insulin sensitivity (IS) compared with the hyperinsulinemic-euglycemic (HIEG) clamp in overweight and obese, non-diabetic, postmenopausal women, before and after a weight loss intervention. RESEARCH DESIGN AND METHODS: Association between Disse index and the HIEG clamp was evaluated in 86 non-diabetic postmenopausal overweight and obese women before and after weight loss. Percentage changes (%Delta) were calculated for several fasting indices and compared with %Delta of HIEG clamp.
RESULTS: We observed a strong correlation between Disse index and HIEG clamp (r=0.69, P<0.001). This association was higher than those of homeostasis model assessment (HOMA), quantitative insulin sensitivity check index (QUICKI), and McAuley indices while no significant difference was observed with Revised-QUICKI. Percent change of Disse index (pre- versus post-weight loss program) was significantly correlated with %Delta of HIEG clamp (r=0.34, P<0.01). This correlation was similar to those observed for the other indices tested.
CONCLUSIONS: We validated the reliability of Disse index in assessing IS in non-diabetic post-menopausal overweight and obese women, before and after weight loss intervention. Disse index may be useful not only for insulin resistant diagnostics in this type of population, but also for the IS follow-up after a weight-loss program and weight stabilization. The presence of lipid elements in this fasting index improves the estimation of IS in overweight and obese non-diabetic post-menopausal women and could add more information about peripheral IS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429699     DOI: 10.1530/EJE-09-0091

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

1.  Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism.

Authors:  Brandon D Kayser; Edi Prifti; Marie Lhomme; Eugeni Belda; Maria-Carlota Dao; Judith Aron-Wisnewsky; Anatol Kontush; Jean-Daniel Zucker; Salwa W Rizkalla; Isabelle Dugail; Karine Clément
Journal:  Metabolomics       Date:  2019-10-11       Impact factor: 4.290

2.  Dietary intervention impact on gut microbial gene richness.

Authors:  Aurélie Cotillard; Sean P Kennedy; Ling Chun Kong; Edi Prifti; Nicolas Pons; Emmanuelle Le Chatelier; Mathieu Almeida; Benoit Quinquis; Florence Levenez; Nathalie Galleron; Sophie Gougis; Salwa Rizkalla; Jean-Michel Batto; Pierre Renault; Joel Doré; Jean-Daniel Zucker; Karine Clément; Stanislav Dusko Ehrlich
Journal:  Nature       Date:  2013-08-29       Impact factor: 49.962

3.  A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial.

Authors:  Yuejun Liu; Aurélie Cotillard; Camille Vatier; Jean-Philippe Bastard; Soraya Fellahi; Marie Stévant; Omran Allatif; Clotilde Langlois; Séverine Bieuvelet; Amandine Brochot; Angèle Guilbot; Karine Clément; Salwa W Rizkalla
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.